GlassScriptPhysician profile
Melanie Mead
NPI 1942257266
$2,704.67
in general payments reported to CMS, 2019-2025
24 companies · $311 in 2025
The $311 reported for 2025 was more than what 75% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $698 · 2022: $675 · 2023: $568 · 2024: $453 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,332.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,332.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $783.49 | 2021-2024 | |
| Astellas Pharma US INC | $234.25 | 2023-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $226.40 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $204.76 | 2021-2025 | |
| Organon LLC | $165.98 | 2021-2025 | Nexplanon |
| Myovant Sciences INC. | $140.21 | 2021-2022 | |
| Therapeuticsmd, INC. | $123.34 | 2021-2022 | |
| Pfizer INC. | $118.14 | 2021-2023 | |
| Exeltis, USA INC. | $112.93 | 2021-2025 | Slynd, Tyblume |
| Millicent US INC | $102.31 | 2023-2025 | Intrarosa, Femring |
| Hologic Sales and Service, LLC | $91.97 | 2021-2025 | Acessa Provu System, Thinprep 2000 Processor, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $62.17 | 2022-2025 | |
| Scynexis, INC. | $46.78 | 2022 | |
| Evofem Biosciences, INC. | $45.26 | 2021-2022 | |
| Minerva Surgical, INC | $39.54 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $38.05 | 2024-2025 | Zurzuvae |
| Biohaven Pharmaceutical Holding Company LTD. | $37.73 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $28.52 | 2024 | |
| Avion Pharmaceuticals | $19.82 | 2023 | Balcoltra |
| Pharmacosmos Therapeutics INC. | $17.60 | 2021 | |
| Mylan Pharmaceuticals INC. | $17.18 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $16.91 | 2023 | Exparel |
| Convatec INC. | $16.21 | 2022 | |
| Lilly USA, LLC | $15.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Mead listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.